New drug candidate nearly doubles survival for patients with aggressive childhood brain tumors

For the first time, researchers have found a potential drug candidate that improved outcomes for patients with a type of childhood brain tumor for which there are no effective treatments. The compound, called ONC201, nearly doubled survival for patients with diffuse midline glioma (DMG) or diffuse intrinsic pontine glioma (DIPG), compared to previous patients.

Read more: https://www.news-medical.net/news/20230817/New-drug-candidate-nearly-doubles-survival-for-patients-with-aggressive-childhood-brain-tumors.aspx